Alnylam PharmaceuticalsALNY 
$261.962.24%24h
2.24%24h
Global rank546
Market cap$32.72B
Change 7d4.01%
YTD Performance37.96%
SP500 benchmarkOutperform
P/E-74.42
P/S17.90
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals (ALNY) Cash on Hand
ALNY Cash on Hand in 2022: $2.44B
According to Alnylam Pharmaceuticals latest financial reports the cash on hand of ALNY is $2.44B, an increase of 11.27% to 2022. At the end of 2022 company had $2.19B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
ALNY Cash on Hand History from 2018 to 2023
-
Value:-
ALNY Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $2.44B | 11.27% |
| 2022 | $2.19B | -9.98% |
| 2021 | $2.44B | 29.94% |
| 2020 | $1.87B | 22.02% |
| 2019 | $1.54B | 41.69% |
| 2018 | $1.08B | - |
View the Top Cash on Hand Companies 
